Recombinant MS4A1 (Rituximab Biosimilar) antibody
The Mammalian Cells Monoclonal anti-MS4A1 (Rituximab Biosimilar) antibody (ABIN7487776) specifically detects MS4A1 (Rituximab Biosimilar) in ELISA.
The antibody is reactive with Human samples.
Catalog No. ABIN7487776
$213.13
Plus shipping costs $50.00
Shipping to:
United States
Delivery in 7 to 10 Business Days
Quick Overview for Recombinant MS4A1 (Rituximab Biosimilar) antibody (ABIN7487776)
Target
MS4A1 (Rituximab Biosimilar)
Antibody Type
Recombinant Antibody
Reactivity
Human
Host
Mammalian Cells
Clonality
Monoclonal
Conjugate
This MS4A1 (Rituximab Biosimilar) antibody is un-conjugated
Application
ELISA
Grade
Research Grade
-
-
Expression System
- Mammalian cells
-
Purpose
- Rituximab Biosimilar - Anti-MS4A1 mAb
-
Characteristics
- Antibody Type: IgG1
-
Purification
- Recombinant antibody expressed in mammalien cells and purified.
-
Isotype
- IgG1
-
-
anti-MS4A1 (Rituximab Biosimilar) antibody
Reactivity: Human, Cynomolgus, Rhesus Monkey FACS Host: Rabbit Chimeric 10F381 unconjugated Recombinant Antibody
-
-
Restrictions
- For Research Use only
-
-
-
Buffer
- PBS pH 7.5
-
Storage
- 4 °C,-20 °C
-
Storage Comment
- 4°C for short term, -20°C for long term
-
-
- MS4A1 (Rituximab Biosimilar)
-
Target Type
- Biosimilar
-
Background
-
Rituximab
Rituximab is a chimeric monoclonal antibody against the protein CD20, which is primarily found on the surface of immune system B cells. When it binds to this protein it triggers cell death. Rituximab is a medication used to treat certain autoimmune diseases and types of cancer. It is used for non-Hodgkin lymphoma, chronic lymphocytic leukemia, rheumatoid arthritis, granulomatosis with polyangiitis, idiopathic thrombocytopenic purpura, pemphigus vulgaris, myasthenia gravis and EpsteinBarr virus-positive mucocutaneous ulcers.
Target
-
You are here:
